Rima Al-awar
Director/Miembro de la Junta en SATELLOS BIOSCIENCE INC. .
Fortuna: - $ al 31/05/2024
Perfil
Rima Al-awar is currently the Director at Satellos Bioscience, Inc. and has been a Member at Ontario Institute for Cancer Research since 2008.
She holds a doctorate degree from North Carolina State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SATELLOS BIOSCIENCE INC
-.--% | 29/05/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Rima Al-awar
| Empresas | Cargo | Inicio |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Director/Miembro de la Junta | 05/12/2021 |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01/01/2008 |
Formación de Rima Al-awar.
| North Carolina State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SATELLOS BIOSCIENCE INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
- Bolsa de valores
- Insiders
- Rima Al-awar
